Print this page    •   Back to Web version of article

International News
Questions for GSK on Investing in Health Care Workers

May 27, 2011

Commenting on GlaxoSmithKline's announcement this week that it will redistribute a portion of its proceeds back to least developed countries (LDCs) to address the shortage of health care workers, Nandini Oomann, director of the HIV/AIDS Monitor at the Center for Global Development, poses two questions for the company on the center's "Global Health Policy" blog and states that GSK "is in a unique position to combine lessons from the aid industry with its own private sector industrial efficiency and wisdom to lead the way for effective (locally derived and implemented, outcome based) private sector investment in global health and development" (5/25).

Back to other news for May 2011


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art62250.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.